BioSherpa™ STS cultured a much greater diversity of bacterial species than control from a bone sample while a patient was on antibiotics for 6 days.
BioSherpa
™ STS
identified multiple strains from a bone sample while a patient was on antibiotics.
BioSherpa™ STS can be used for a variety of biological samples. In this example we see how it can be used to coax causative pathogens out of a bone sample. This is extremely significant because the patient was on vancomycin and piperacillin tazobactam for 6 days before culture.
This infection also had an aggressive soft tissue component and required immediate broad spectrum treatment before eventual bone culture (from amputation).
BioSherpa
™ STS
yielded multiple strains whereas controls yielded none.
BioSherpa™ STS could potentially help elucidate the infectious agent in samples that traditionally yield negative results.
This patient required more aggressive antibiotic therapy. Reliance on standard bone culture techniques would have left the patient under-treated and at high risk for failure.